lercea glp-1 oral ampoules 🛑 SCAM ALERT 🛑 We've been made aware of a fraudulent advert using Obesity UK's name and logo to promote a product called Weight Loss Solution. It falsely claims endorsements Oral GLP-1 Analogues (Semaglutide) -

Medi-Cal dropping coverage Perhaps the most significant change for low-income populations was Medi-Cal, California Medicaid program, dropping GLP-1 weight loss coverage effective January 1, 2026

[DOI] [PMC free article] [PubMed] [Google Scholar] 177.Tillner J., Posch M.G., Wagner F., Teichert L., Hijazi Y., Einig C., Keil S., Haack T., Wagner M., Bossart M., Larsen P.J

So your prescriber will work with you to find the closest equivalent

10.1016/j.peptides.2019.170194 14

Journal of Clinical Endocrinology and Metabolism 2020

These agents are FDA-approved primarily for the management of type 2 diabetes mellitus and, for specific products (Wegovy, Saxenda, Zepbound), for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity